Which Bits of 'It Runs in the Family' Are Testable?

Heart disease does run in families — but it runs in two quite different ways, and only one of them can be pinned down by a test. A small number of families carry a single faulty gene that causes a specific, named heart condition, and that gene can be looked for directly. Far more families simply share a raised background risk, built from many small genetic effects layered on top of a shared diet, shared smoking habits and a shared way of living. No single test will ever find that second kind, because there is no single thing to find.

The distinction matters the moment you sit down with a life insurance application, because the two kinds are treated very differently. It also matters for your own health, because one of them can be screened for and managed for years before it does any harm. So the useful question is not really whether heart disease runs in families — it plainly does — but which part of your family's history can be tested for and which part cannot.

What follows splits inherited cardiac risk into the named single-gene conditions a test can find and the general clustering it cannot, and then sets out what each one means when an underwriter looks at it.

The short answer: two kinds of "runs in the family"

When someone says heart disease runs in their family, they are usually describing one of two situations without realising they are different.

The first is a single-gene inherited heart condition. Here one specific fault, passed down through the family, is enough on its own to cause the problem. These conditions are uncommon, they often have a clear pattern across the generations, and — crucially — many of them can be confirmed by a named gene test once a specialist has a reason to look.

The second, and far more common, is polygenic clustering. This is what most people actually have when several relatives have had heart attacks or angina. There is no single faulty gene. Instead there are many common genetic variants, each nudging the risk up a little, combined with the habits and circumstances a family tends to share. It behaves like a family trait, but there is no one thing a test could isolate.

Both are real, and both can raise your risk. But only the first is testable, and that single fact shapes almost everything about how the subject is handled — clinically and on an insurance form.

The conditions a named gene test can actually find

A handful of inherited heart conditions are caused by a fault in a single gene, and for these a test genuinely exists. The main ones you are likely to encounter are:

• Familial hypercholesterolaemia (FH) — an inherited fault in the way the body clears LDL cholesterol, producing very high readings from early in life and, untreated, early heart disease. It is the most common of the single-gene conditions and is very often undiagnosed, which is why we treat it separately in high cholesterol that runs in the family and has a name.
• Hypertrophic cardiomyopathy (HCM) — a thickening of the heart muscle that can run in families and is a recognised cause of sudden death in young people. It is usually first found on an echocardiogram, and a gene fault can often be identified afterwards.
• Dilated cardiomyopathy — a stretching and weakening of the heart muscle, a proportion of which is inherited.
• Inherited rhythm disorders — long QT syndrome, Brugada syndrome and related conditions that disturb the heart's electrical rhythm and can be present with a normal-looking heart on a scan.

The important thing about all of these is how the test is done. You do not get a meaningful answer from a shop-bought ancestry kit. Testing runs through an NHS inherited cardiac conditions service or clinical genetics service, and it is normally offered where the family pattern, or a relative's confirmed diagnosis, gives a reason to look. The NHS describes these pathways in its guidance on cardiomyopathy, and the British Heart Foundation sets out how families are assessed for inherited heart conditions.

The far commoner kind no test will find

Most family clustering of heart disease is not one of the conditions above. It is coronary artery disease — the furring and narrowing of the arteries that leads to heart attacks and angina — appearing in several relatives because they share both a genetic tendency and a way of living.

There is no gene test for this. You cannot walk into a clinic and be told yes or no, because the risk is spread across many common variants that each do a small amount, and it is entangled with cholesterol, blood pressure, weight, diabetes, smoking and physical activity. That sounds like bad news, but it is the opposite. The things driving polygenic risk are precisely the things that can be measured, watched and changed. A raised cholesterol can be treated. Blood pressure can be brought down. Smoking can be stopped. None of that is available to someone whose risk sits in a single unchangeable gene.

So the honest position for most people who say heart disease runs in their family is this: there is nothing to test, but there is a great deal to measure and act on. Telling your GP that close relatives had early heart disease is worth doing, because it changes the threshold at which they check your own numbers and start thinking about prevention.

What a result means for a life insurance application

Here the two kinds part company sharply, and the rule is not intuitive.

A predictive genetic test result — a gene fault found before you have any symptoms or diagnosis — cannot be asked for or used on a UK life insurance application. That protection comes from the Code on Genetic Testing and Insurance, the agreement between HM Government and the Association of British Insurers. It applies to inherited cardiac gene results in exactly the same way it applies to any other predictive result. There is a single, narrow exception in the whole Code, and it is Huntington's disease above a set amount of cover — a neurological condition, not a heart one, so it never touches this subject. We explain that one carve-out in the £500,000 line in Huntington's life cover.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance.

A clinical diagnosis is different. If hypertrophic cardiomyopathy was found on your echocardiogram, if long QT was identified on your ECG, if you take medication for a heart condition or have a device fitted, those are ordinary medical facts. An insurer can ask about them, and you must answer with reasonable care if it does. The gene test that may have followed the diagnosis stays protected; the diagnosis, the scan finding, the symptoms and the treatment do not.

Family history sits in a third place again. Whatever the tests say about you, application forms routinely ask about conditions in close relatives, and how far that question reaches is worth understanding before you fill it in — we cover it in how far back the family history question actually goes.

Why two relatives can be underwritten so differently

This is the part that surprises people. Two siblings from the same family, carrying the same background risk, can be offered noticeably different terms — and it is not unfairness, it is a direct consequence of the rule above.

Imagine one sibling has been through an inherited cardiac conditions clinic, had a normal scan and a predictive gene test that cannot be asked for. The other has been diagnosed with hypertrophic cardiomyopathy on an echo and takes medication for it. The first sibling has almost nothing an underwriter can act on beyond family history; the second has a diagnosis that is fully disclosable. The gene they may or may not share is invisible to the insurer in both cases. What moves the decision is what has actually been found clinically in each individual.

It also explains why being screened and found normal is not something to be afraid of. A reassuring scan is ordinary medical evidence in your favour, and a predictive gene test — whatever it shows — cannot be used against you. The one situation that genuinely causes trouble is answering a clear question inaccurately, whether about your own diagnosis or a relative's, which is a subject in its own right.

If heart disease runs in your family, what to do

The practical steps are the same whether or not a single gene turns out to be involved.

• Tell your GP the specifics. Which relatives, what they had, and how old they were when it happened. A parent or sibling with early heart disease, or a young sudden death in the family, can meet the threshold for referral to an inherited cardiac conditions service.
• Get your own numbers checked. Cholesterol, blood pressure, blood sugar and weight are the levers that matter for the common polygenic risk, and they are measurable now rather than hypothetical.
• Do not rely on a consumer DNA kit. These do not test properly for the single-gene cardiac conditions, and a reassuring or alarming ancestry report is not a clinical answer either way.
• Sort cover around your real position, not your fears. Because a predictive result cannot be used, most people with a family history of heart disease have far less standing in their way than they assume. If you want to know where you stand, you can get life insurance quotes and let an FCA-authorised broker work from your actual health and history rather than a worst case.

If a family history has already prompted you to think about wills and paperwork as well as cover, some of the practical after-death admin — from probate disbursements to how a couple holds their home — is set out in our guide to family history, inherited risk and the odds.

Scotland and Northern Ireland

The clinical pathways run across the whole UK. Inherited cardiac conditions services and clinical genetics services operate in Scotland through NHS Scotland and in Northern Ireland through Health and Social Care, as they do in England and Wales, and referral is through your GP wherever you live.

The insurance protection is UK-wide too. The Code on Genetic Testing and Insurance is a national agreement between HM Government and the Association of British Insurers, and it applies to residents across England, Scotland, Wales and Northern Ireland alike. There is no separate Scottish or Northern Irish rule that would let an insurer ask for a predictive cardiac gene result it could not ask for elsewhere. What can differ, as always, is the individual insurer's own list of questions and how it weighs a family history — which is a matter of underwriting, not of nation.

Frequently asked questions

Does heart disease run in families?

Yes, in two different ways. A small number of families carry a single faulty gene causing conditions such as familial hypercholesterolaemia, hypertrophic cardiomyopathy or long QT syndrome. Far more common is a general clustering of risk, built from many small genetic effects combined with shared diet, smoking and exercise habits. The first kind can be tested for; the second cannot, but it can be measured and managed.

Can I be tested for inherited heart disease?

Named single-gene conditions can be tested for, usually through an inherited cardiac conditions or clinical genetics service, and normally where the family pattern or a relative's diagnosis justifies it. There is no test for the general familial clustering that lies behind most heart disease; that is assessed through cholesterol, blood pressure and other measurable risk factors rather than through a gene.

How do insurers treat inherited heart conditions?

A predictive gene result cannot be asked for. A diagnosis reached on a scan or an ECG can be, along with symptoms, medication and any device fitted. That is why two relatives in one family can be underwritten very differently: the decision follows what has actually been found clinically in each of them, not the gene they may share.